Tech-assisted self-selection concurred with clinician-assessed eligibility in >90% of cases
Effect on gut microbiome emerges as another benefit of statin therapy
Updated guidance on identification and strategies for management
Web-based self-selection tool aims to achieve long-sought nonprescription statin access
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Q&A with the director of our dedicated program for statin intolerance
A closer look at specific drug concerns
The stakes of — and reasons behind — the ‘cult of statin denial’
An editorial from Cardiovascular Medicine specialists
No higher risk of type 2 diabetes found with statin use